QUIT — Achieve Life Sciences Share News
0.000.00%
- $746.03m
- $573.64m
Brief: Achieve Life Sciences Presents 52-Week Cytisinicline Results For Smoking And Vaping Cessation At Chest 2026
Brief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Achieve Life Sciences Appoints Kaitlyn Tuson As Senior Vice President, Marketing And Communications
Brief: Achieve Life Sciences - Enters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock
Achieve Life Sciences Q2 loss widens on warrant liabilities
Achieve Life Sciences Inc expected to post a loss of 16 cents a share - Earnings Preview
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug (updated)
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug
Advisory: Alert wrongly tagged to Achieve Life Sciences withdrawn
Achieve Life Sciences Q1 loss narrows more than expected
U.S. STOCKS ON THE MOVE-Netflix, J.B. Hunt, Arxis
U.S. STOCKS ON THE MOVE-Abbott, J.B. Hunt, Myseum
Achieve Life Sciences rises as it names new CEO ahead of key drug launch
Advisory: Alert wrongly tagged to Achieve Life Sciences withdrawn
Brief: Achieve Life Sciences May Offer Up To $300 Million In Securities
Advisory: Alert wrongly tagged to Achieve Life Sciences withdrawn
Achieve Life Sciences Q3 net loss widens
Brief: Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences